Heilongjiang ZBD Pharmaceutical Co., Ltd.

¥5.01As of Sun 8 Nov 2026, 12:00 UTC
SSE:603567Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (12.68%)
Div yield —
ROE (22.49%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.27
PE TTM —
TSR TTM (55.66%)
Mkt cap ¥4.702B
ROIC (13.09%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥5.52
10.08%
(64.56%)
Sell 0|10|1|6|3
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.13
0.13
0.14
0.14
21.73%
21.03%
19.24%
23.60%
Revenue¥M
221.0
224.8
233.9
229.2
7.05%
7.29%
7.95%
1.06%
Peers (US$704.8M)
Cap (US$)
PE
712.5M
—
Capital
TTM
5Y
10Y
Leveragex
1.378
0.675
0.698
EBIT/Intx
3.372
0.402
0.329
Own earn%
939.18
188.52
165.41
Sh yield%
42.67
33.94
37.33
Owners
Insiders/Inst%
1.18
77.48
Short interest%
1.89
SBC / revenue%
0.84
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
12–18
$1 testx
0.0
Incr. ROIC%
2